These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17827843)

  • 1. Successful treatment of refractory angina pectoris due to multivessel coronary spasm with valsartan.
    Sakamoto T; Shintomi Y; Yoshimura M; Ogawa H
    Intern Med; 2007; 46(17):1425-9. PubMed ID: 17827843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
    Ishii H; Kobayashi M; Kurebayashi N; Yoshikawa D; Suzuki S; Ichimiya S; Kanashiro M; Sone T; Tsuboi H; Amano T; Uetani T; Harada K; Marui N; Murohara T
    Am J Cardiol; 2013 Aug; 112(3):363-8. PubMed ID: 23623047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
    Neri Serneri GG; Boddi M; Modesti PA; Coppo M; Cecioni I; Toscano T; Papa ML; Bandinelli M; Lisi GF; Chiavarelli M
    Circ Res; 2004 Jun; 94(12):1630-7. PubMed ID: 15131005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-cerebrovascular protective effects of valsartan in high-risk hypertensive patients with coronary artery disease (from the Kyoto Heart Study).
    Shiraishi J; Sawada T; Koide M; Yamada H; Matsubara H;
    Am J Cardiol; 2012 May; 109(9):1308-14. PubMed ID: 22325086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do valsartan and losartan have the same effects in the treatment of coronary artery disease?
    Iwata A; Miura S; Imaizumi S; Kiya Y; Nishikawa H; Zhang B; Shimomura H; Kumagai K; Matsuo K; Shirai K; Saku K
    Circ J; 2007 Jan; 71(1):32-8. PubMed ID: 17186975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to drug therapy in unstable angina on the basis of coronary angiography findings.
    Uchida T; Kaneko N; Tanino S; Ogawa H; Iwasaki T; Sumiyoshi T; Hosoda S
    Jpn Circ J; 1992 Nov; 56(11):1166-71. PubMed ID: 1453541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan-induced acute pancreatitis.
    Can B; Sali M; Batman A; Yilmaz H; Korkmaz U; Celebi A; Senturk O; Hulagu S
    Intern Med; 2014; 53(7):703-5. PubMed ID: 24694480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy of low- (80 mg/day) and high- (160-320 mg/day) dose valsartan in the prevention of in-stent restenosis after implantation of bare-metal stents in type B2/C coronary artery lesions.
    Peters S
    Am J Cardiovasc Drugs; 2008; 8(2):83-7. PubMed ID: 18422391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem for long-term therapy of coronary arterial spasm.
    Schroeder JS; Lamb IH; Ginsburg R; Bristow MR; Hung J
    Am J Cardiol; 1982 Feb; 49(3):533-7. PubMed ID: 7058764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial.
    Peters S; Trümmel M; Meyners W; Koehler B; Westermann K
    Int J Cardiol; 2005 Feb; 98(2):331-5. PubMed ID: 15686787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac angiotensin is upregulated in the hearts of unstable angina patients.
    Luft FC
    Circ Res; 2004 Jun; 94(12):1530-2. PubMed ID: 15217917
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery spasm-related acute coronary syndrome in patients with coexisting spasm of angiographically normal coronary artery and fixed narrowing of the remaining vessels.
    Yang NI; Hung MJ; Cherng WJ
    Angiology; 2007; 58(2):156-60. PubMed ID: 17495263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
    Sander GE; Giles TD
    Expert Opin Pharmacother; 2015 Apr; 16(5):763-70. PubMed ID: 25747524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary arteries: evaluation by 24-hour 12-lead electrocardiography with computer analysis.
    Onaka H; Hirota Y; Shimada S; Kita Y; Sakai Y; Kawakami Y; Suzuki S; Kawamura K
    J Am Coll Cardiol; 1996 Jan; 27(1):38-44. PubMed ID: 8522708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation.
    Shrikhande G; Khaodhiar L; Scali S; Lima C; Hubbard M; Dudley K; Ganda O; Ferran C; Veves A
    J Vasc Surg; 2006 Apr; 43(4):760-70; discussion 770-1. PubMed ID: 16616233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.